The Proprietary Pharmaceutical Business of Abbott Is Now AbbVie
AbbVie, the contract manufacturing business of Abbott, offers manufacturing services for biologics, potent, drug product and bulk active pharmaceutical ingredients .
Through its rich heritage from its predecessor, AbbVie has been in the business of developing and producing pharmaceutical products for more than 120 years. Over 25 years, we have offered Contract Manufacturing to provide customers with high-quality, innovative, cost-effective services in the area of Biologics, Potent, Drug Product and Bulk Active Pharmaceutical Ingredients to benefit the companies that put their trust in us.
Learn more about our services by visiting www.abbviecontractmfg.com.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
